TORSEMIDE + SPIRONOLACTONE in pharma franchise in Chhattisgarh

TORSEMIDE + SPIRONOLACTONE in PCD pharma franchise in Imphal

TORSEMIDE + SPIRONOLACTONE in top pharma company in Shimla

TORSEMIDE + SPIRONOLACTONE in pcd pharma supplier in Hyderabad

TORSEMIDE + SPIRONOLACTONE phama franchise company in india
TORSEMIDE + SPIRONOLACTONE phama distributor in Nagpur

Home/Products /torsemide-10-mg-spironolactone-mg-tablet

Torslide S 10-50 Tablet

Composition : Torsemide 10mg + Spironolactone 50mg Tablets

Dosage Form : Tablet

Packaging Type : Blister

Packaging : 10*15

Price : ₹195/-

Torslide S 10-50 Tablet is a dual-action diuretic formulation combining Torsemide (10 mg), a loop diuretic, and Spironolactone (50 mg), a potassium-sparing diuretic. This combination is used primarily to treat fluid retention (edema) and high blood pressure (hypertension) in patients suffering from heart failure, liver disease, and kidney disorders.

Torsemide functions by increasing urine production, which helps the body remove excess fluid, reducing swelling and lowering blood pressure. Spironolactone, on the other hand, helps maintain potassium levels in the body while counteracting the effects of aldosterone, a hormone that causes fluid retention. Together, they provide a balanced approach to managing edema and hypertension by preventing potassium loss while effectively eliminating excess fluid.

This medication is especially beneficial for individuals requiring long-term diuretic therapy, as it helps maintain proper electrolyte balance and reduces complications associated with excessive fluid retention. It improves breathing, decreases swelling in the legs and abdomen, and enhances cardiovascular function.

Read More

About the Product

Torslide S 10-50 Tablet is a dual-action diuretic formulation combining Torsemide (10 mg), a loop diuretic, and Spironolactone (50 mg), a potassium-sparing diuretic. This combination is used primarily to treat fluid retention (edema) and high blood pressure (hypertension) in patients suffering from heart failure, liver disease, and kidney disorders.

Torsemide functions by increasing urine production, which helps the body remove excess fluid, reducing swelling and lowering blood pressure. Spironolactone, on the other hand, helps maintain potassium levels in the body while counteracting the effects of aldosterone, a hormone that causes fluid retention. Together, they provide a balanced approach to managing edema and hypertension by preventing potassium loss while effectively eliminating excess fluid.

This medication is especially beneficial for individuals requiring long-term diuretic therapy, as it helps maintain proper electrolyte balance and reduces complications associated with excessive fluid retention. It improves breathing, decreases swelling in the legs and abdomen, and enhances cardiovascular function.

May cause dizziness, dehydration, low blood pressure, electrolyte imbalance, muscle cramps, nausea, or increased urination.

Used for the treatment of hypertension and edema associated with heart failure, liver cirrhosis, and kidney disorders.

Should be used under medical supervision, with regular monitoring of electrolytes, kidney function, and blood pressure.

Store at 15°C to 30°C, in a cool and dry place, away from moisture and direct sunlight.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Strategic Advisory

Ms. Shiwani Dhiman

VP-Strategic Outreach & Engagement

Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.

View Professional Profile

Start Your Journey

Partner With Cafoli

Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our rapidly growing network of successful franchise partners and turn your ambitions into reality. Limited Territories Available — Don’t Miss Out!

Quick Navigation